These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10726946)

  • 21. A national audit of the management of HIV-2 in adults in the UK.
    Tickell-Painter M; Chadwick DR; Deayton JR; Reeves I; van Halsema CL
    Int J STD AIDS; 2022 Oct; 33(11):1013-1017. PubMed ID: 36062733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapy.
    Madge S; Smith CJ; Lampe F; Sabin CA; Youle M; Johnson MA; Phillips AN
    HIV Med; 2008 Apr; 9(4):208-13. PubMed ID: 18298577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination against hepatitis B in an HIV outpatients' department: an audit against national vaccination guidelines.
    Williams H; Bevan MA; Tong CY; Kulasegaram R
    Int J STD AIDS; 2011 Jul; 22(7):405-6. PubMed ID: 21729961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015.
    Molloy A; Curtis H; Burns F; Freedman A;
    BMC Infect Dis; 2017 Sep; 17(1):619. PubMed ID: 28903730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of HIV infected patients: applicability of guidelines. Results of an nationwide Austrian survey].
    Armbruster C; Gmeinhart B
    Acta Med Austriaca; 1998; 25(1):21-6. PubMed ID: 9576021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An audit of antiretroviral prescribing in HIV patients. Yorkshire Audit Group for HIV-related diseases.
    Monteiro E
    Int J STD AIDS; 1999 Oct; 10(10):692-3. PubMed ID: 10582642
    [No Abstract]   [Full Text] [Related]  

  • 27. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 28. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
    Patel N; Abdelsayed S; Veve M; Miller CD
    Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression.
    Smith CJ; Phillips AN; Dauer B; Johnson MA; Lampe FC; Youle MS; Tyrer M; Staszewski S
    HIV Med; 2009 Jan; 10(1):19-27. PubMed ID: 19018880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit on virological efficacy of anti-retroviral therapy in a specialist infectious disease clinic.
    Reyad A; Waldron C; Canning R; O'Shea D; Coakley P; McConkey S
    Ir Med J; 2009 Jun; 102(6):186-8. PubMed ID: 19722358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients.
    Hart E; Curtis H; Wilkins E; Johnson M
    HIV Med; 2007 Apr; 8(3):186-91. PubMed ID: 17461863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV/AIDS treatment guidelines released.
    Randall P
    NIAID AIDS Agenda; 1997 Aug; ():1-2, 12. PubMed ID: 11364605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time taken to undetectable viral load, following the initiation of HAART.
    Currie S; Rogstad KE; Piyadigamage A; Herman S
    Int J STD AIDS; 2009 Apr; 20(4):265-6. PubMed ID: 19304973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
    Perez-Molina JA; Rubio R; Rivero A; Pasquau J; Suárez-Lozano I; Riera M; Estébanez M; Santos J; Sanz-Moreno J; Troya J; Mariño A; Antela A; Navarro J; Esteban H; Moreno S;
    Lancet Infect Dis; 2015 Jul; 15(7):775-84. PubMed ID: 26062881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the 2011 UK post-exposure prophylaxis for HIV following sexual exposure guidelines: a regional retrospective audit.
    Bennett A; Wainwright E; Lord E; Oduru M; Chen F; Desmond N; Sherrard J; Duncan S
    Int J STD AIDS; 2015 Sep; 26(10):746-8. PubMed ID: 25332226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usage of stavudine (D4T) - a retrospective analysis in a South London hospital.
    Lechelt M; McCormick S; de Ruiter A
    Int J STD AIDS; 2007 Mar; 18(3):215-7. PubMed ID: 17362559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.